| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S1461145710000933 |
| P698 | PubMed publication ID | 20716398 |
| P50 | author | Peter McGuffin | Q7175787 |
| Marcella Rietschel | Q20742720 | ||
| Robert Keers | Q37828808 | ||
| Katherine J. Aitchison | Q37828818 | ||
| Ole Mors | Q41638422 | ||
| Rudolf Uher | Q43273047 | ||
| Neven Henigsberg | Q45729464 | ||
| Aleksandra Szczepankiewicz | Q47451507 | ||
| Erik Roj Larsen | Q56380953 | ||
| Joanna Twarowska-Hauser | Q89213422 | ||
| P2093 | author name string | Anne Farmer | |
| Wolfgang Maier | |||
| Anna Placentino | |||
| Astrid Zobel | |||
| Daniel Souery | |||
| Petra Kalember | |||
| Jana Strohmaier | |||
| Julien Mendlewicz | |||
| Aleksandra Szczepankiewicz | |||
| Dejan Kozel | |||
| Mojca Zvezdana Dernovsek | |||
| Joanna M Gray | |||
| P2860 | cites work | A New Depression Scale Designed to be Sensitive to Change | Q29614720 |
| Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry | Q30909447 | ||
| Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies | Q34101548 | ||
| Measuring depression: comparison and integration of three scales in the GENDEP study | Q34699544 | ||
| Adverse reactions to antidepressants | Q35000528 | ||
| Tolerability issues during long-term treatment with antidepressants | Q35775232 | ||
| Pharmacological management of atypical antipsychotic-induced weight gain. | Q37165503 | ||
| Non-pharmacological management of antipsychotic-induced weight gain: systematic review and meta-analysis of randomised controlled trials. | Q37231472 | ||
| Selective serotonin reuptake inhibitor discontinuation: side effects and other factors that influence medication adherence | Q40173529 | ||
| Body mass index and response to antidepressants in depressed research subjects | Q43209738 | ||
| Nortriptyline for treatment-resistant depression. | Q44318537 | ||
| Major depression, antidepressant medication and the risk of obesity | Q44891681 | ||
| Obesity among outpatients with major depressive disorder. | Q45054146 | ||
| Antidepressive-drug-induced bodyweight gain is associated with polymorphisms in genes coding for COMT and TPH1. | Q45993661 | ||
| Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a STAR*D report. | Q46002104 | ||
| Body weight as a predictor of antidepressant efficacy in the GENDEP project | Q46096011 | ||
| Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression | Q46104577 | ||
| What happens with adverse events during 6 months of treatment with selective serotonin reuptake inhibitors? | Q46597997 | ||
| Antidepressant-induced weight gain: a comparison study of four medications | Q47176365 | ||
| Weight gain. A side-effect of tricyclic antidepressants | Q47235261 | ||
| Weight Gain in Depression Remitted with Antidepressants: Pharmacological or Recovery Effect? | Q47283733 | ||
| Amitriptyline, weight gain and carbohydrate craving: a side effect | Q47364382 | ||
| Overweight and obesity affect treatment response in major depression | Q48301599 | ||
| BMI, sex, and antidepressant response | Q51932499 | ||
| Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches. | Q53018948 | ||
| Fluoxetine Versus Sertraline and Paroxetine in Major Depressive Disorder | Q56138336 | ||
| The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients | Q69903875 | ||
| P433 | issue | 3 | |
| P921 | main subject | pharmacology | Q128406 |
| P304 | page(s) | 367-375 | |
| P577 | publication date | 2010-08-18 | |
| P1433 | published in | The International Journal of Neuropsychopharmacology | Q7742309 |
| P1476 | title | Changes in body weight during pharmacological treatment of depression | |
| P478 | volume | 14 |
| Q36083244 | A Post Hoc Analysis of the Effect of Weight on Efficacy in Depressed Patients Treated With Desvenlafaxine 50 mg/d and 100 mg/d |
| Q42684907 | Bifidobacteria exert strain-specific effects on stress-related behavior and physiology in BALB/c mice |
| Q35567642 | Can Online Consumers Contribute to Drug Knowledge? A Mixed-Methods Comparison of Consumer-Generated and Professionally Controlled Psychotropic Medication Information on the Internet |
| Q35852531 | Effect of comedication of bupropion and other antidepressants on body mass index |
| Q34243328 | Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause |
| Q104064811 | Functions of galanin, spexin and kisspeptin in metabolism, mood and behaviour |
| Q26765430 | Is increased antidepressant exposure a contributory factor to the obesity pandemic? |
| Q38859885 | Managing comorbid obesity and depression through clinical pharmacotherapies |
| Q33622056 | Metabolic syndrome in bipolar disorder and schizophrenia: dietary and lifestyle factors compared to the general population |
| Q47342530 | No Influence of Body Weight on Serum Levels of Antidepressants |
| Q38135881 | Overweight and obesity in youth with developmental disabilities: a call to action |
| Q92022051 | Phenotypic factors associated with amisulpride-induced weight gain in first-episode psychosis patients (from the OPTiMiSE cohort) |
| Q48478654 | The effect of escitalopram on metabolic parameters in patients with major depressive disorder, generalised anxiety disorder, and panic disorder: A prospective 6-month follow-up study |
| Q61444891 | Twelve Chinese herbal preparations for the treatment of depression or depressive symptoms in cancer patients: a systematic review and meta-analysis of randomized controlled trials |
Search more.